Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/1995
03/07/1995US5395840 Hypotensive agents; atherosclerosis
03/07/1995US5395835 Naphthalamides as central nervous system agents
03/07/1995US5395834 New benzopyran compounds
03/07/1995US5395830 Method of treating osteoporosis with 1α,24(R)-dihydroxy-22(E)-dehydro-vitamin D3
03/07/1995US5395826 Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for their preparation and their use
03/07/1995US5395824 Dipeptide derivative and prophylactic and therapeutic agent for bone diseases containing the same
03/07/1995CA1334655C De-mannosyl teicoplanin derivatives
03/07/1995CA1334646C Transdermal penetration enhancers
03/04/1995CA2117656A1 Naphthoxazines
03/02/1995WO1995006068A1 Novel polysaccharide and radioprotective agent containing the same as active ingredient
03/02/1995WO1995006063A1 Factor for fibroblast colony forming unit
03/02/1995WO1995006046A1 Indole derivatives as thromboxane a2 antagonists
03/02/1995WO1995006044A1 Amide and urea derivatives as 5ht1d receptor antagonists
03/02/1995WO1995006020A1 New diphenylhexene
03/02/1995WO1995005853A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
03/02/1995WO1995005846A1 Neural regeneration using human bone morphogenetic proteins
03/02/1995WO1995005833A1 Pharmaceutical composition for immunoenhancement therapy
03/02/1995WO1995005822A1 Inhibition of smooth muscle cell migration by (r)-amlodipine
03/02/1995WO1995005821A1 Di- and tetra-hydrobenzo[f]quinolin-3-ones
03/02/1995WO1995005814A1 Pharmaceutical compositions comprising metal complexes
03/02/1995WO1995005810A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production
03/02/1995WO1995005805A1 Process for conditioning substances
03/02/1995CA2170279A1 Indole derivatives as thromboxane a2 antagonists
03/02/1995CA2170253A1 Pharmaceutical compositions comprising metal complexes
03/02/1995CA2169945A1 Factor for fibroblast colony forming unit
03/02/1995CA2169750A1 Di- and tetra-hydrobenzo[f]quinolin-3-ones
03/02/1995CA2169210A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production
03/01/1995EP0640689A2 p40 Homodimer of interleukin-12
03/01/1995EP0640620A2 Methods and reagents for inhibiting cholesterol absorption in humans mediated by pancreatic esterase receptor protein
03/01/1995EP0640617A1 Substituted azepino (2,1-a)isoquinoline compounds
03/01/1995EP0640612A1 Novel derivatives from 2-(1H)-quinolinone, process for their preparation and pharmaceutical compositions containing them
03/01/1995EP0640607A1 2-Beta-alkenyl-penem-sulfonyl compounds as beta-lacterase inhibitors
03/01/1995EP0640599A1 4-Aminopyrimidine derivatives
03/01/1995EP0640596A1 N-pyridazinyl-benzene (naphthalene-, biphenyl-) sulfonamide derivatives, their preparation and their use as endothelin antagonists
03/01/1995EP0640593A1 Substituted benzoylguanidines, process for their preparation, their use as medicine or in diagnostic and medicines containing them
03/01/1995EP0640592A1 N-acylated tricyclic azaheterorings useful as vasopressin antagonists
03/01/1995EP0640588A1 Orthosubstituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
03/01/1995EP0640346A1 Uses of sulphated sugars against inflammation
03/01/1995EP0640345A2 Composition for inhibiting transmission of AIDS, containing silver salts with a detergent
03/01/1995EP0640342A2 Pentoxifylline and/or depogen for improving the tissue antioxidant status
03/01/1995EP0640143A1 Senescent cell derived inhibitors of dna synthesis
03/01/1995EP0640129A1 Inhibition of cell adhesion protein-carbohydrate interactions
03/01/1995EP0640099A1 Peptides having tachykinin antagonist activity
03/01/1995EP0640086A1 NOVEL MERCAPTOACETYLAMIDO PYRIDAZO 1,2]PYRIDAZINE, PYRAZOLO 1,2]PYRIDAZINE, PYRIDAZO 1,2-a] 1,2]DIAZEPINE AND PYRAZOLO 1,2-a] 1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE
03/01/1995EP0640085A1 Fused imidazole and triazole derivatives as 5-ht1 receptor agonists
03/01/1995EP0640081A1 Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-ht antagonists
03/01/1995EP0640078A1 Nitric 1,2-benzo-isothiazolyl-3(2h)one-1,1-dioxide esters, preparation method therefor and drugs containing same
03/01/1995EP0640065A1 Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation
03/01/1995EP0639980A1 Use of platelet derived growth factor in ophthalmic wound healing
03/01/1995EP0639979A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
03/01/1995EP0639976A1 Use of terfenadine derivatives as antihistaminics in a hepatically impaired patient
03/01/1995EP0639975A1 Heterocyclic-substituted pyridine compounds and uses
03/01/1995EP0580753B1 Pyrimidine derivatives for enhancing antitumor activity
03/01/1995EP0462264B1 Heterocyclic derivatives, method for preparing same, and their therapeutic applications as paf-antagonists
03/01/1995EP0406428B1 Peptide derivatives and their use
03/01/1995CN1099392A Compounds containing a fused bicyclic ring and processes therefor
03/01/1995CN1099388A Heteroatom-bearing ligands and metal complexes thereof
03/01/1995CN1099264A Cell differentiation inducer comprising acyclic polyisoprenoid
03/01/1995CN1027759C Novel acetylcholinesterase inhibitors
03/01/1995CA2130971A1 Sulfonamide endothelin antagonists
03/01/1995CA2117600A1 2-(1h)-quinolinone derivatives; process for preparing the same and pharmaceutical compositions containing them
02/1995
02/28/1995US5393869 Polypeptides; hormone therapy for osteoporosis, hypertension and hypoparathyroidism
02/28/1995US5393786 Administering certain phenolic compounds
02/28/1995US5393775 Benzopyran compounds
02/28/1995US5393774 Phenylethanolamines, pharmaceutical compositions containing these compounds and process for preparing them
02/28/1995US5393768 Treating hypersensitivity reactions such as asthma
02/28/1995US5393763 Methods for inhibiting bone loss
02/28/1995US5393762 Pharmaceutical agents for treatment of emesis
02/28/1995US5393755 Polycyclic guanine derivatives
02/28/1995US5393753 Substituted imidazobenzazepines
02/28/1995US5393749 Method of treating osteoporosis with 1 α25-dihydroxy-22(E)-dehydro-vitamin D3
02/28/1995US5393748 Methylenebisphosphonic acid derivatives
02/28/1995US5393740 Neurotensin Hexapeptides
02/28/1995US5393739 Use of bone morphogenetic protein in synergistic combination with TGF-β for bone repair
02/28/1995US5393737 Cytotoxic drug conjugates for treatment of neoplastic diseases
02/28/1995CA1334589C Benzodiazepine derivatives
02/28/1995CA1334575C Substitution fluid preparation comprising 3-hydroxybutyric acid (beta-hydroxybutyric acid) and its salts
02/26/1995CA2130385A1 Inhibition of phosphatidylinositol 3-kinase with 17.beta.-hydroxywortmannin and analogs thereof
02/23/1995WO1995005456A1 Pharmaceutical composition comprising phosphatase or a derivative thereof
02/23/1995WO1995005455A1 Pharmaceutical composition comprising phosphatase or a derivative thereof
02/23/1995WO1995005412A1 Cosmetic melanins
02/23/1995WO1995005386A1 Phenethylamine compounds
02/23/1995WO1995005377A1 Heterocycles useful as neurokinin antagonists
02/23/1995WO1995005376A1 Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelin antagonists
02/23/1995WO1995005375A1 Indole derivatives as 5-alpha-reductase-1-inhibitors
02/23/1995WO1995005364A2 Inhibitors of biogenic amine transporters
02/23/1995WO1995005363A1 Amidine derivatives with nitric oxide synthetase activities
02/23/1995WO1995005360A1 Phenoxyphenyl cyclopentenyl hydroxyureas
02/23/1995WO1995005358A1 Use of phenols and phenol derivates as medicaments with fibrinogen-reducing effect
02/23/1995WO1995005191A1 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF-β ACTIVITY
02/23/1995WO1995005189A1 Class i mhc modulation of surface receptor activity
02/23/1995WO1995005185A1 Method of preventing neutrophil mediated connective tissue damage
02/23/1995WO1995005180A1 Methods and compositions for inhibiting uridine secretion
02/23/1995WO1995005174A1 Antipsychotic method
02/23/1995WO1995005167A2 Treatment of adverse effects associated with administration of extracellular hemoglobin
02/23/1995WO1995005155A1 Use of oligosaccharides for the prevention and treatment of tissue ageing
02/23/1995DE3991484C2 Pharmaceutical composition containing a specific inhibitor of the enzymatic conversion of protoporphyrinogen to protoporphyrin IX by protoporphyrinogen oxidase
02/23/1995CA2169360A1 Methods and compositions for stimulating and inhibiting tgf-.beta. activity
02/23/1995CA2169287A1 Inhibitors of biogenic amine transporters
02/23/1995CA2169285A1 Class i mhc modulation of surface receptor activity
1 ... 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 ... 1564